Novartis Ag (NVSEF) Goodwill (2009 - 2026)

Novartis Ag has disclosed Goodwill across 12 years of filings, most recently posting $1.4 billion for Q1 2026.

• Goodwill for Q1 2026 came in at $1.4 billion, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $1.4 billion (changed N/A YoY), and the FY2025 annual result was $25.6 billion, up 3.28% from the prior year.
• Goodwill came in at $1.4 billion for Q1 2026 at Novartis Ag, down from $25.6 billion in the prior quarter.
• In the past five years, Goodwill ranged from a high of $29.5 billion in Q2 2023 to a low of $12.0 million in Q1 2024.
• The 5-year median for Goodwill is $24.0 billion (2023), against an average of $15.4 billion.
• Peak annual rise in Goodwill reached 18011.66% in 2023, while the deepest fall reached 20.34% in 2023.
• Novartis Ag's Goodwill stood at $29.3 billion in 2022, then dropped by 20.34% to $23.3 billion in 2023, then climbed by 6.06% to $24.8 billion in 2024, then advanced by 3.28% to $25.6 billion in 2025, then slumped by 94.52% to $1.4 billion in 2026.
• The last three Goodwill figures came in at $1.4 billion (Q1 2026), $25.6 billion (Q4 2025), and $25.6 billion (Q2 2025), per Business Quant data.